| Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide R Stupp, PY Dietrich, SO Kraljevic, A Pica, I Maillard, P Maeder, R Meuli, ... Journal of Clinical Oncology 20 (5), 1375-1382, 2002 | 1087 | 2002 |
| Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial H Bartelink, P Maingon, P Poortmans, C Weltens, A Fourquet, J Jager, ... The lancet oncology 16 (1), 47-56, 2015 | 691 | 2015 |
| Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β= 1.4 (0.9–2.2) Gy R Miralbell, SA Roberts, E Zubizarreta, JH Hendry International Journal of Radiation Oncology* Biology* Physics 82 (1), e17-e24, 2012 | 547 | 2012 |
| Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors R Miralbell, A Lomax, L Cella, U Schneider International Journal of Radiation Oncology* Biology* Physics 54 (3), 824-829, 2002 | 505 | 2002 |
| Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer DB Husarik, R Miralbell, M Dubs, H John, OT Giger, A Gelet, ... European journal of nuclear medicine and molecular imaging 35, 253-263, 2008 | 370 | 2008 |
| Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group P Poortmans, A Bossi, K Vandeputte, M Bosset, R Miralbell, P Maingon, ... Radiotherapy and Oncology 84 (2), 121-127, 2007 | 334 | 2007 |
| Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy E Lecumberri, YM Dupertuis, R Miralbell, C Pichard Clinical nutrition 32 (6), 894-903, 2013 | 281 | 2013 |
| Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis P Ost, BA Jereczek-Fossa, N Van As, T Zilli, A Muacevic, K Olivier, ... European urology 69 (1), 9-12, 2016 | 273 | 2016 |
| 18F‐choline and/or 11C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen … H Vees, F Buchegger, S Albrecht, H Khan, D Husarik, H Zaidi, D Soloviev, ... BJU international 99 (6), 1415-1420, 2007 | 272 | 2007 |
| The role of radiotherapy in the treatment of subtotally resected benign meningiomas R Miralbell, RM Linggood, S De la Monte, K Convery, JE Munzenrider, ... Journal of neuro-oncology 13, 157-164, 1992 | 242 | 1992 |
| Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. R Miralbell, S Bieri, B Mermillod, C Helg, G Sancho, B Pastoors, A Keller, ... Journal of clinical oncology 14 (2), 579-585, 1996 | 206 | 1996 |
| Guidelines for primary radiotherapy of patients with prostate cancer D Boehmer, P Maingon, P Poortmans, MH Baron, R Miralbell, ... Radiotherapy and oncology 79 (3), 259-269, 2006 | 201 | 2006 |
| Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases U Schick, S Jorcano, P Nouet, M Rouzaud, H Vees, T Zilli, O Ratib, ... Acta oncologica 52 (8), 1622-1628, 2013 | 182 | 2013 |
| Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy S Martinet, M Ozsahin, Y Belkacémi, C Landmann, P Poortmans, ... International Journal of Radiation Oncology* Biology* Physics 55 (4), 892-898, 2003 | 168 | 2003 |
| 11C-acetate PET in the early evaluation of prostate cancer recurrence S Albrecht, F Buchegger, D Soloviev, H Zaidi, H Vees, HG Khan, A Keller, ... European journal of nuclear medicine and molecular imaging 34, 185-196, 2007 | 166 | 2007 |
| Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes AJ Lomax, L Cella, D Weber, JM Kurtz, R Miralbell International Journal of Radiation Oncology* Biology* Physics 55 (3), 785-792, 2003 | 161 | 2003 |
| A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer … DY Song, KK Herfarth, M Uhl, MJ Eble, M Pinkawa, B Van Triest, ... International Journal of Radiation Oncology* Biology* Physics 87 (1), 81-87, 2013 | 156 | 2013 |
| Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042-26042) DC Weber, C Ares, S Villa, SM Peerdeman, L Renard, BG Baumert, ... Radiotherapy and oncology 128 (2), 260-265, 2018 | 153 | 2018 |
| Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial C Vrieling, E van Werkhoven, P Maingon, P Poortmans, C Weltens, ... JAMA oncology 3 (1), 42-48, 2017 | 153 | 2017 |
| Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy R Miralbell, HD Suit, D Phil, HJ Mankin, LR Zuckerberg, MA Stracher, ... International Journal of Radiation Oncology* Biology* Physics 18 (3), 535-540, 1990 | 147 | 1990 |
